Company shall have to allocate the newly-issued shares to accommodate the right adjustment of ECF-W3 in the number of not exceeding 12,396,000 shares. The adjustments in the exercise price to purchase the
12,396,000 shares. The adjustments in the exercise price to purchase the ordinary shares and the exercise ratio to purchase the ordinary shares, including the method to calculate the said adjustments, as
), the Company shall have to allocate the newly-issued shares to accommodate the right adjustment of ECF-W3 in the number of not exceeding 12,396,000 shares. The adjustments in the exercise price to
) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2021 Company Year 31/12/2021 2021 Consolidated Year 31/12/2021 2021 Company Q2 30/06/2021
) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2021 Company Year 31/12/2021 2021 Consolidated Year 31/12/2021 2021 Reviewed Company Q3 30/09/2021
) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2020 Reviewed Company Q3 30/09/2020 2020 Reviewed Consolidated Q3 30/09/2020 2020 Reviewed Company Q2
2020 Company Year 31/12/2020 Unqualified opinion 2020 Consolidated Year 31/12/2020 Unqualified opinion 2020 Reviewed Company Q3 30/09/2020 2020 Reviewed Consolidated Q3 30/09/2020